876301-26-7 Usage
Heterocyclic compound
Yes
It contains a ring structure with both carbon and non-carbon atoms (nitrogen and bromine).
Ring system
Triazolopyridine
The compound features a fused ring system consisting of a triazole and a pyridine.
Bromine substituent
At the 6-position
A bromine atom is attached to the 6th position of the triazolopyridine ring.
2-(1-methylethyl)phenyl group
Attached to the 3-position
A phenyl group with an isopropyl (2-(1-methylethyl)) substituent is attached to the 3rd position of the triazolopyridine ring.
Potential applications
Medicinal chemistry and drug discovery
Due to its unique structure and potential biological activities, the compound may be useful in the development of new drugs and therapies.
Further research and testing
Necessary
To fully understand the properties and potential uses of 1,2,4-Triazolo[4,3-a]pyridine, 6-bromo-3-[2-(1-methylethyl)phenyl]-, additional research and testing are required.
Check Digit Verification of cas no
The CAS Registry Mumber 876301-26-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,3,0 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 876301-26:
(8*8)+(7*7)+(6*6)+(5*3)+(4*0)+(3*1)+(2*2)+(1*6)=177
177 % 10 = 7
So 876301-26-7 is a valid CAS Registry Number.
876301-26-7Relevant academic research and scientific papers
Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
-
Page/Page column 44, (2008/06/13)
A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
